Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Eris Lifesciences Ltd.
BSE Code 540596
ISIN Demat INE406M01024
Book Value (Rs) 182.56
NSE Code ERIS
Dividend Yield % 0.83
Market Cap(Rs Mn) 121082.24
TTM PE(x) 34.79
TTM EPS(Rs) 25.58
Face Value (Rs) 1  
Type:
(Rs. in Million)
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax4046.434421.983944.973313.503173.58
Adjustment1398.39492.52440.72442.37305.01
Changes In working Capital-1755.36-299.0153.27-526.50-532.38
Cash Flow after changes in Working Capital3689.464615.494438.963229.372946.21
Cash Flow from Operating Activities2917.383782.643753.612711.662229.96
Cash Flow from Investing Activities-9821.01-3196.10-3233.581232.32-50.51
Cash Flow from Financing Activities6880.25-446.99-823.95-3345.91-2210.53
Net Cash Inflow / Outflow-23.38139.55-303.92598.07-31.08
Opening Cash & Cash Equivalents508.70369.15673.0775.00106.08
Cash & Cash Equivalent on Amalgamation / Take over / Merger74.900000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations00000
Closing Cash & Cash Equivalent560.22508.70369.15673.0775.00